Compare ARWR & RMBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARWR | RMBS |
|---|---|---|
| Founded | 2003 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 10.2B |
| IPO Year | 1993 | 1997 |
| Metric | ARWR | RMBS |
|---|---|---|
| Price | $67.81 | $125.83 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 7 |
| Target Price | $73.70 | ★ $102.00 |
| AVG Volume (30 Days) | ★ 2.6M | 1.5M |
| Earning Date | 02-05-2026 | 02-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 30.64 |
| EPS | N/A | ★ 2.10 |
| Revenue | ★ $829,448,000.00 | $678,488,000.00 |
| Revenue This Year | N/A | $29.03 |
| Revenue Next Year | N/A | $16.19 |
| P/E Ratio | ★ N/A | $52.40 |
| Revenue Growth | ★ 23258.15 | 31.05 |
| 52 Week Low | $9.57 | $40.12 |
| 52 Week High | $76.76 | $114.55 |
| Indicator | ARWR | RMBS |
|---|---|---|
| Relative Strength Index (RSI) | 57.08 | 77.95 |
| Support Level | $61.65 | $88.50 |
| Resistance Level | $68.24 | $95.35 |
| Average True Range (ATR) | 3.79 | 5.32 |
| MACD | -0.69 | 2.98 |
| Stochastic Oscillator | 45.29 | 89.01 |
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
Rambus Inc is a semiconductor solutions provider offering high-speed, high-security computer chips and Silicon intellectual property. The company's key products include memory interface chips, built for high speed and efficiency; silicon IP, providing high-speed memory and chip-to-chip connection technology; and architecture licenses, which allow customers to use portions of Rambus' patented inventions for their own digital electronics. The firm receives the majority of its revenue from the United States, Taiwan, Asia, Japan, and Singapore.